PARTICIPATION OF IASIS PHARMA IN THE “WORLD PHARMACEUTICAL EXHIBITION CPhI” BARCELONA 2023

06/11/2023|All articles, Company news, Horizon 2020, Press Room, Research & development, Research and development projects, Scientific conferences|

Fira Barcelona Gran Via Spain, 24-26/10/2023 IASIS PHARMA participated with great success in the Global Exhibition of the Pharmaceutical industry, CPhI. For 2023, the exhibition was held on October 24 & 26, 2023 at Barcelona's Gran Via Exhibition Center. The organizers registered thousands of visitors and over 2,000 exhibitors, while hundreds were the professionals of [...]

INAUGURATION OF THE MASTIC RESEARCH CENTER (M.R.C.)

23/06/2023|All articles, Exploiting the gifts of Greek nature, Horizon 2020, Press Room, Research & development, Research and development projects|

On Saturday, April 29th 2023, the Mastic Research Center (M.R.C.) opening was held in Kallimasia of Chios. Many people was present such as from the medical, pharmaceutical, business, political and academic field, as well as the mastic producers and guests. This project will be a reliable body that will coordinate academic interests and scientific research [...]

MIDTERM MEETING OF THE EXANDAS RESEARCH PROGRAM PARTICIPANTS IN THE CONTEXT OF Η2020-MSCA-RISE 2015

12/06/2017|All articles, Horizon 2020, Research & development|

The first meeting of the research program under the distinct title “EXANDAS” of the Marie Sklodowska Curie Actions (MSCA) program successfully took place on 21-22 April 2017. The program aims to exploit the aromatic plants’ by-products, Chios Mastic included, for the purpose of developing novel pharmaceutical products. The program’s coordinator is Assistant Prof. N. Aligiannis, [...]

KICK OFF MEETING OF THE ΕΧΑΝDAS PROGRAM

14/04/2016|All articles, Horizon 2020, Research & development|

ATHENS, 01-02/04/2016 The kick-off meeting of the research program under the distinct title   “EXANDAS” of the Marie Sklodowska Curie Actions (MSCA) programs was successfully organized on 1-2 April 2016. The specific program aims  to exploit the aromatic plants’ by-products such as the Chios Mastic for the purpose of developing novel pharmaceutical products. The meeting took place [...]

PARICIPATION IN THE HORIZON PROGRAM

18/11/2015|All articles, Horizon 2020, Research & development|

BRUSSELS, 10/11/2015 IASIS PHARMA proudly announces its participation in a program of H2020. The program Horizon 2020 is the financing framework of the EU for research and Innovation that will cover the period 2014-2020, with a budget of approximately 80 billion Euros. The program supports the strategy "Europe 2020" that promotes research and innovation as the [...]

Load More Posts